Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
GKOS
#950
Glaukos Corporation
120.0
6
-1.27%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-1.27%
Monthly Change
-1.47%
6 month change
+25.63%
Year Change
+1.48%
Previous Close
121.6
0
Open
118.9
3
Bid
Ask
Low
118.7
2
High
120.0
6
Volume
233
Markets
US Stock Market
Healthcare
GKOS
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
Stifel réitère sa recommandation sur Glaukos avec une dynamique produits
Stifel reiterates Glaukos stock rating on product momentum
Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook
Needham relève l’objectif de cours de Glaukos grâce à la croissance d’iDose et Epioxa
Needham raises Glaukos stock price target on iDose, Epioxa growth
These Analysts Boost Their Forecasts On Glaukos Following Q4 Results - Glaukos (NYSE:GKOS)
Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript
Glaukos (GKOS) Reports Q4 Earnings: What Key Metrics Have to Say
Glaukos (GKOS) Reports Q4 Loss, Beats Revenue Estimates
Glaukos publie ses résultats alors que les lancements d’iDose et Epioxa convergent
Glaukos earnings on deck as iDose, Epioxa launches converge
Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth